Trending
International lawAi safetyStrait of hormuzPower rankingAi infrastructureLabor economicsFood labelingSleep scienceIndo-pacific postureClimate thresholdsAi regulationStorylineEnergy marketsData privacySuspension dynamicsInvestment structuresGlobal payrollSports medicineGravity modelQuantum computingFood standardsCognitive developmentSilicon economicsAsylum rightsFood safety standardsPhase dynamicsStatistical methodsVehicle identificationFood safetyFilm classification

FDA Schedules Advisory Committee Review for Galleri Multi-Cancer Early Detection Blood Test: full timeline

Every report in this developing story, from the first to the latest.

  1. FDA Schedules Advisory Committee Review for Galleri Multi-Cancer Early Detection Blood Test

    The FDA will convene an expert panel in September to review GRAIL's Galleri blood test, a pivotal step that could lead to the first regulatory approval for a multi-cancer early detection screening tool.

  2. FDA Staff Report Finds No Major Safety Concerns With Galleri Multicancer Blood Test

    Briefing documents released ahead of an upcoming advisory committee meeting indicate the FDA has not identified significant safety or accuracy issues with Grail's multi-cancer early detection test.

  3. FDA Advisory Panel Backs First Multi-Cancer Early Detection Blood Test

    A federal advisory committee has voted to recommend approval of Grail's Galleri blood test, which screens for over 50 types of cancer.